The first successful total pancreatectomy with islet autotransplant (TPIAT) for the treatment of chronic pancreatitis was performed in 1977. Since then, the procedure continues to gain widespread acceptance as a reliable and effective treatment option to (1) improve or cure the associated chronic pain syndrome; (2) prevent the development of brittle type 3c diabetes mellitus by alleviating hypoglycemic complications associated with total pancreatectomy; (3) and prevent the potential development of pancreatic cancer in this high-risk population. TPIAT is a complex procedure with a wide range of potential complications that are intrinsic to its two components: total pancreatectomy (TP) and islet autotransplantation (IAT). Mounting evidence in the literature supports TPIAT as an approach that can be done safely at experienced centers using open, laparoscopic, and/or robotic techniques with little morbidity and mortality. From the surgical perspective, the procedure is standardized and can be safely performed in a
Rainer W. G. Gruessner (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: